These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


273 related items for PubMed ID: 738638

  • 1. [Immunotherapy of malignant melanomas].
    Macher E.
    Haematol Blood Transfus; 1978; 21():285-91. PubMed ID: 738638
    [No Abstract] [Full Text] [Related]

  • 2. [Use of immunotherapy in the treatment of malignant melanoma of the skin].
    Kristensen E.
    Ugeskr Laeger; 1976 Feb 16; 138(8):468-73. PubMed ID: 1258215
    [No Abstract] [Full Text] [Related]

  • 3. [Possibilities of an immunotherapy of malignant skin tumors with particular consideration of malignant melanomas (author's transl)].
    Schöpf E.
    Ther Umsch; 1976 Aug 16; 33(8):538-42. PubMed ID: 1006610
    [No Abstract] [Full Text] [Related]

  • 4. Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin.
    MacGregor AB, Falk RE, Landi S, Ambus U, Samuel ES, Langer B.
    Can J Surg; 1977 Jan 16; 20(1):25-30. PubMed ID: 832200
    [Abstract] [Full Text] [Related]

  • 5. [Results in the use of immunochemotherapy in patients with cutaneous malignant melanoma].
    Calbo L, Gorgone S, Palmeri R, Salibra M, Melita P.
    Chir Ital; 1983 Aug 16; 35(4):519-25. PubMed ID: 6680859
    [Abstract] [Full Text] [Related]

  • 6. Experience with BCG adjuvant immunotherapy in stage II malignant melanoma.
    Peter HH, Deutschmann EM, Schultheis W, Deicher H.
    Dev Biol Stand; 1983 Aug 16; 38():537-40. PubMed ID: 344106
    [Abstract] [Full Text] [Related]

  • 7. [Immunoreactivity in patients with surgically removed melanoma in the course of BCG vaccination (author's transl)].
    Lochman I, Kyselá T, Machálek J, Lochmanová A, Beska F.
    Cesk Dermatol; 1980 Aug 16; 55(6):372-7. PubMed ID: 7460040
    [No Abstract] [Full Text] [Related]

  • 8. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
    Trapeznikov NN, Iavorskiĭ VV, Kadagidze ZG, Malaev SG, Kupin VI.
    Vopr Onkol; 1977 Aug 16; 23(8):27-33. PubMed ID: 906404
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical administration of BCG-immunotherapy in malignant melanoma (author's transl)].
    Wätzig V, Knopf B.
    Arch Geschwulstforsch; 1979 Aug 16; 49(2):140-5. PubMed ID: 475550
    [Abstract] [Full Text] [Related]

  • 12. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
    Bluming AZ, Vogel CL, Ziegler JL, Kiryabwire JW.
    J Natl Cancer Inst; 1972 Jan 16; 48(1):17-24. PubMed ID: 4652371
    [No Abstract] [Full Text] [Related]

  • 13. [Immunological aspects of melanoma].
    Sjögren H.
    Lakartidningen; 1976 Feb 11; 73(7):528-30. PubMed ID: 1250045
    [No Abstract] [Full Text] [Related]

  • 14. [Cancer immunotherapy in dermatological view (author's transl)].
    Lübbe D, Gstöttner R.
    Arch Geschwulstforsch; 1980 Feb 11; 50(2):182-5. PubMed ID: 7436703
    [Abstract] [Full Text] [Related]

  • 15. Results of adjuvant BCG immunotherapy in malignant melanoma.
    Wätzig V, Knopf B.
    Arch Geschwulstforsch; 1981 Feb 11; 51(6):493-6. PubMed ID: 7332442
    [Abstract] [Full Text] [Related]

  • 16. Immunotherapy of malignant disease (Part 2).
    MacGregor AB, Falk RE.
    J R Coll Surg Edinb; 1976 Jan 11; 21(1):43-9. PubMed ID: 765453
    [No Abstract] [Full Text] [Related]

  • 17. Adjuvant BCG immunotherapy for stage I and II malignant melanoma.
    Silver HK, Ibrahim EM, Evers JA, Thomas JW, Murray RN, Spinelli JJ.
    Can Med Assoc J; 1983 Jun 01; 128(11):1291-5. PubMed ID: 6342739
    [Abstract] [Full Text] [Related]

  • 18. [Melanoma therapy].
    Kleeberg UR.
    Dtsch Med Wochenschr; 1976 Jun 04; 101(23):904-8. PubMed ID: 773624
    [No Abstract] [Full Text] [Related]

  • 19. Immunotherapy in malignant melanomaa.
    Homes EC, Morton DL, Eilber FR, Golub SE, Sulit HL.
    Natl Cancer Inst Monogr; 1976 Nov 04; 44():85-6. PubMed ID: 799763
    [Abstract] [Full Text] [Related]

  • 20. Immunotherapy of melanoma with intralesional BCG.
    Bornstein RS, Mastrangelo MJ, Sulit H, Chee D, Yarbro JW, Prehn LM, Prehn RT.
    Natl Cancer Inst Monogr; 1973 Dec 04; 39():213-20. PubMed ID: 4595320
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.